Golden et al. reported four patients with lung cancer who were treated with radiotherapy (35 Gy/10 f in target area) in combination with granulocyte macrophage colony-stimulating factor; the other tumor decreased by more than 30% outside of target [25]. This evidence concerns the gene CSF2 and lung cancer.